Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout miceSPIEGELSTEIN, Ofer; MERRIWEATHER, Michelle Y; WICKER, Ned J et al.Birth defects research. Clinical and molecular teratology. 2003, Vol 67, Num 12, pp 974-978, issn 1542-0752, 5 p.Article

Knockout mouse model for Fxr2: a model for mental retardationBONTEKOE, Carola J. M; MCILWAIN, Kellie L; NGAN CHING CHENG et al.Human molecular genetics (Print). 2002, Vol 11, Num 5, pp 487-498, issn 0964-6906Article

Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceISOHERRANEN, Nina; YAGEN, Boris; SPIEGELSTEIN, Ofer et al.British journal of pharmacology. 2003, Vol 139, Num 4, pp 755-764, issn 0007-1188, 10 p.Article

Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-α-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicityISOHERRANEN, Nina; SPIEGELSTEIN, Ofer; BIALER, Meir et al.Epilepsia (Copenhagen). 2003, Vol 44, Num 10, pp 1280-1288, issn 0013-9580, 9 p.Article

The use of behavioral test batteries : Effects of training historyMCILWAIN, Kellie L; MERRIWEATHER, Michelle Y; YUVA-PAYLOR, Lisa A et al.Physiology & behavior. 2001, Vol 73, Num 5, pp 705-717, issn 0031-9384Article

Mouse Fkbp8 activity is required to inhibit cell death and establish dorso-ventral patterning in the posterior neural tubeWONG, Rebecca Lee Yean; WLODARCZYK, Bogdan J; KYUNG SOO MIN et al.Human molecular genetics (Print). 2008, Vol 17, Num 4, pp 587-601, issn 0964-6906, 15 p.Article